This finding, while preliminary, may help us to understand the underlying molecular mechanism of UBE2C in pan-cancer tumorigenesis, and UBE2C might be a diagnostic biomarker and a therapeutic target across many cancers. The gene discussed is UBE2C; the disease is cancer.